Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer

Medicine and Dentistry

• Breast Cancer 100%
• RNA Binding Protein 100%
• Neoplasm 80%
• Malignant Neoplasm 40%
• Estrogen Receptor 40%
• Protein Expression 20%
• Tissue Microarray 20%
• Breast Cancer Cell Line 20%
• Colon 20%
• Genetic Transcription 20%
• Colorectal Cancer 20%
• Prognostic Factor 20%
• Proto Oncogene 20%
• Small Interfering RNA 20%
• Western Blot 20%
• Recurrence Free Survival 20%
• RNA Metabolism 20%
• Antibody Specificity 20%
• Immunohistochemistry 20%
• Gene Silencing 20%
• Tamoxifen 20%
• Antibodies 20%
• Hormone Receptor 20%

Biochemistry, Genetics and Molecular Biology

• RNA-binding Protein 100%
• Estrogen Receptor 66%
• Colon 33%
• Small Interfering RNA 33%
• Gene Silencing 33%
• Cancer Cell 33%
• Monospecific Antibody 33%
• Protein Expression 33%
• Western Blot 33%
• Genetic Transcription 33%
• Tissue Microarray 33%
• Hormone Receptor 33%
• Proto Oncogene 33%
• Recurrence Free Survival 33%
• Antibody Specificity 33%
• RNA Metabolism 33%

Immunology and Microbiology

• Protein RNA Binding 100%
• Monospecific Antibody 33%
• Western Blot 33%
• Colon 33%
• Gene Silencing 33%
• Protein Expression 33%
• Proto Oncogene 33%
• Genetic Transcription 33%
• Recurrence Free Survival 33%
• Antibody Specificity 33%
• RNA Metabolism 33%
• Breast Cancer Cell Line 33%